This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Idogen Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Idogen.
Key information
50.6%
Earnings growth rate
76.1%
EPS growth rate
Biotechs earnings growth | 37.0% |
Revenue growth rate | -122.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 10 May 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | N/A | -12 | -12 | -12 | 2 |
12/31/2024 | N/A | -12 | -11 | -12 | 2 |
12/31/2023 | N/A | -37 | -39 | -38 | 2 |
3/31/2023 | 1 | -44 | -42 | -40 | N/A |
12/31/2022 | 0 | -48 | -52 | -51 | N/A |
9/30/2022 | 3 | -50 | -55 | -53 | N/A |
6/30/2022 | 11 | -41 | -54 | -52 | N/A |
3/31/2022 | 12 | -39 | -48 | -48 | N/A |
12/31/2021 | 14 | -39 | -41 | -40 | N/A |
9/30/2021 | 13 | -33 | -36 | -36 | N/A |
6/30/2021 | 7 | -33 | -34 | -33 | N/A |
3/31/2021 | 8 | -31 | -37 | -36 | N/A |
12/31/2020 | 8 | -27 | -28 | -28 | N/A |
9/30/2020 | 7 | -27 | -25 | -25 | N/A |
6/30/2020 | 6 | -29 | -27 | -27 | N/A |
3/31/2020 | 5 | -32 | -25 | -25 | N/A |
12/31/2019 | 4 | -33 | -36 | -35 | N/A |
9/30/2019 | 7 | -29 | -29 | -28 | N/A |
6/30/2019 | 6 | -30 | -28 | -26 | N/A |
3/31/2019 | 5 | -27 | -30 | -27 | N/A |
12/31/2018 | 4 | -28 | -14 | -10 | N/A |
9/30/2018 | N/A | -30 | -24 | -18 | N/A |
6/30/2018 | N/A | -29 | -24 | -19 | N/A |
3/31/2018 | N/A | -25 | -18 | -12 | N/A |
12/31/2017 | N/A | -21 | -24 | -20 | N/A |
9/30/2017 | 0 | -18 | -17 | -15 | N/A |
6/30/2017 | 0 | -14 | -11 | -9 | N/A |
3/31/2017 | 0 | -13 | -12 | -12 | N/A |
12/31/2016 | 0 | -13 | N/A | -11 | N/A |
9/30/2016 | 0 | -12 | N/A | -12 | N/A |
6/30/2016 | 0 | -12 | N/A | -12 | N/A |
3/31/2016 | 0 | -10 | N/A | -10 | N/A |
12/31/2015 | 0 | -10 | N/A | -9 | N/A |
9/30/2015 | 0 | -8 | N/A | -8 | N/A |
6/30/2015 | 1 | -6 | N/A | -5 | N/A |
3/31/2015 | 0 | -4 | N/A | -3 | N/A |
12/31/2014 | 0 | -2 | N/A | -2 | N/A |
12/31/2013 | 0 | 0 | N/A | 0 | N/A |
12/31/2012 | 0 | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IDOGEN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: IDOGEN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: IDOGEN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: IDOGEN is forecast to have no revenue next year.
High Growth Revenue: IDOGEN is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if IDOGEN's Return on Equity is forecast to be high in 3 years time